Horan Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Horan Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-7,939	Closed	-$492K	–	61
2018 Q3	$492K	Sell	7,939 -229,965	-97%	-$13.6M	0.09%	47
2018 Q2	$13.2M	Sell	237,904 -1,980	-0.8%	-$107K	2.58%	16
2018 Q1	$15.2M	Sell	239,884 -6,003	-2%	-$386K	3.29%	13
2017 Q4	$15.1M	Sell	245,887 -2,069	-0.8%	-$129K	2.99%	14
2017 Q3	$15.8M	Buy	247,956 +5,075	+2%	+$296K	3.28%	12
2017 Q2	$13.5M	Buy	242,881 +142,170	+141%	+$7.74M	2.96%	14
2017 Q1	$5.48M	Buy	+100,711	New	+$5.52M	1.25%	28

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Horan Capital Management's BMY Position: Q4 2018 in Review

Horan Capital Management sold out of Bristol-Myers Squibb (BMY) in Q4 2018, closing a stake of 7,939 shares — an estimated $492K sold.

Horan Capital Management first reported a position in BMY in Q1 2017 and held it in 7 quarters. The position peaked at $15.8M in Q3 2017. 1,766 funds tracked by Wall St. Rank hold BMY as of Q4 2018.

Horan Capital Management reported no remaining Bristol-Myers Squibb position as of Q4 2018 after selling out during the quarter.
Horan Capital Management sold 7,939 Bristol-Myers Squibb shares in Q4 2018, an estimated $492K.
Horan Capital Management first reported a position in Bristol-Myers Squibb in Q1 2017 and held it in 7 quarters.
Horan Capital Management's Bristol-Myers Squibb position peaked at $15.8M in Q3 2017.
1,766 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2018.

Based on Horan Capital Management's 13F filing for Q4 2018, filed 14 Jan 2019.